Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 33,564 | 23,259 | 17,141 | 11,587 | 10,450 |
| Cost of Goods | 18,376 | 14,791 | 10,214 | 11,391 | 9,672 |
| Gross Profit | 15,188 | 8,468 | 6,927 | 196 | 778 |
| Operating Expenses | 25,384 | 22,073 | 19,151 | 19,232 | 17,279 |
| Operating Income | -9,820 | -12,814 | -12,010 | -18,645 | -15,829 |
| Interest Expense | 1,928 | 1,892 | 1,914 | 1,519 | 343 |
| Other Income | -208 | -78 | -107 | -3,416 | -174 |
| Pre-tax Income | -11,956 | -14,784 | -14,031 | -23,580 | -16,346 |
| Income Tax | N/A | 0 | N/A | -442 | N/A |
| Net Income Continuous | -11,956 | -14,784 | -14,031 | -23,138 | -16,346 |
| Net Income | $-11,956 | $-14,784 | $-14,031 | $-23,138 | $-16,346 |
| EPS Basic Total Ops | -0.36 | -0.44 | -0.42 | -0.71 | -0.49 |
| EPS Basic Continuous Ops | -0.35 | -0.44 | -0.42 | -0.71 | -0.50 |
| EPS Diluted Total Ops | -0.36 | -0.44 | -0.42 | -0.71 | -0.49 |
| EPS Diluted Continuous Ops | -0.35 | -0.44 | -0.42 | -0.71 | -0.50 |
| EBITDA(a) | $-6,963 | $-10,329 | $-9,567 | $-16,265 | $-14,184 |